Reduction of Raf kinase inhibitor protein expression by Bcr-Abl contributes to chronic myelogenous leukemia proliferation.

Documenti analoghi

• Reduction of Raf Kinase Inhibitor Protein Expression by Bcr-Abl Contributes to Chronic Myelogenous Leukemia Proliferation
  di: Takemura, Tomonari, et al.
  Pubblicazione: (2010)
• Depletion of pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
  di: Hirano, Isao, et al.
  Pubblicazione: (2010)
• Depletion of Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatases 1 and 2 by Bcr-Abl Promotes Chronic Myelogenous Leukemia Cell Proliferation through Continuous Phosphorylation of Akt Isoforms
  di: Hirano, Isao, et al.
  Pubblicazione: (2009)
• Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
  di: Ross, Theodora S, et al.
  Pubblicazione: (2014)
• Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
  di: Kelliher, M A, et al.
  Pubblicazione: (1990)